These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2714810

  • 1. Hyperaluminaemia associated with oral citrate and aluminium hydroxide.
    Kirschbaum BB, Schoolwerth AC.
    Hum Toxicol; 1989 Jan; 8(1):45-7. PubMed ID: 2714810
    [Abstract] [Full Text] [Related]

  • 2. Hyperaluminemia in renal failure: the influence of age and citrate intake.
    Bakir AA, Hryhorczuk DO, Ahmed S, Hessl SM, Levy PS, Spengler R, Dunea G.
    Clin Nephrol; 1989 Jan; 31(1):40-4. PubMed ID: 2914409
    [Abstract] [Full Text] [Related]

  • 3. Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids.
    Kirschbaum BB, Schoolwerth AC.
    Am J Med Sci; 1989 Jan; 297(1):9-11. PubMed ID: 2913801
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic aluminium hydroxide and hyperaluminaemia in intensive care.
    Mackway-Jones K, Cove-Smith R, Lawler P.
    Intensive Care Med; 1987 Jan; 13(4):293-4. PubMed ID: 3497185
    [Abstract] [Full Text] [Related]

  • 5. The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium.
    Fleming LW, Stewart Wk, Fell GS, Halls DJ.
    Clin Nephrol; 1982 May; 17(5):222-7. PubMed ID: 7094439
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aluminum-citrate interaction in end-stage renal disease.
    Rudy D, Sica DA, Comstock T, Davis J, Savory J, Schoolwerth AC.
    Int J Artif Organs; 1991 Oct; 14(10):625-9. PubMed ID: 1748529
    [Abstract] [Full Text] [Related]

  • 9. Hyperaluminaemia in critically ill patients: role of antacid therapy and impaired renal function.
    Ittel TH, Gladziwa U, Mück W, Sieberth HG.
    Eur J Clin Invest; 1991 Feb; 21(1):96-102. PubMed ID: 1907560
    [Abstract] [Full Text] [Related]

  • 10. Calcium carbonate as a phosphate binder in dialysis patients: evaluation of an enteric-coated preparation and effect of additional aluminium hydroxide on hyperaluminaemia.
    Ittel TH, Schäfer C, Schmitt H, Gladziwa U, Sieberth HG.
    Klin Wochenschr; 1991 Jan 22; 69(2):59-67. PubMed ID: 2027271
    [Abstract] [Full Text] [Related]

  • 11. [Kinetics of aluminum absorption and serum concentration in chronic renal insufficiency].
    Sárszegi Z, Jobst K, Nagy J.
    Orv Hetil; 2000 Aug 27; 141(35):1915-7. PubMed ID: 11019592
    [Abstract] [Full Text] [Related]

  • 12. Effect of calcium supplement preparation containing small amounts of citrate on the absorption of aluminium in normal subjects and in renal failure patients.
    Nestel AW, Meyers AM, Paiker J, Rollin HB.
    Nephron; 1994 Aug 27; 68(2):197-201. PubMed ID: 7830856
    [Abstract] [Full Text] [Related]

  • 13. [Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide].
    Tahiri Y, Moriniere P, Jaudon MC, Dkhissi H, Rosa A, Fournier A.
    Nephrologie; 1983 Aug 27; 4(3):129-33. PubMed ID: 6633778
    [Abstract] [Full Text] [Related]

  • 14. The bioavailability of 26Al-labelled aluminium citrate and aluminium hydroxide in volunteers.
    Priest ND, Talbot RJ, Austin JG, Day JP, King SJ, Fifield K, Cresswell RG.
    Biometals; 1996 Jul 27; 9(3):221-8. PubMed ID: 8696074
    [Abstract] [Full Text] [Related]

  • 15. [Effect on serum aluminium levels of continued ingestion of aluminium gels by patients with chronic renal insufficiency (author's transl)].
    Boukari M, Rottembourg J, Jaudon MC, Clavel JP, Legrain M, Galli A.
    Nouv Presse Med; 1978 Jan 14; 7(2):85-8. PubMed ID: 349501
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of citrate on plasma aluminium concentration and aluminium excretion in the rat.
    Lote CJ, Saunders HC, Wood JA, Spencer AJ.
    Clin Sci (Lond); 1992 Oct 14; 83(4):431-5. PubMed ID: 1330405
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk of orally administered aluminium hydroxide and results of withdrawal.
    Bournerias F, Monnier N, Reveillaud RJ.
    Proc Eur Dial Transplant Assoc; 1983 Oct 14; 20():207-12. PubMed ID: 6657657
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic aluminium hydroxide and hyperaluminaemia in intensive care.
    Graf H.
    Intensive Care Med; 1988 Oct 14; 14(4):445-6. PubMed ID: 3403784
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.